No significant differences were noted between the groups in pregnancy course and outcome, including pregnancy screening tests (nuchal translucency, serum biomarkers, alpha-fetoprotein test and early and late ultrasound anatomical survey), complication rates (gestational diabetes and preeclampsia) and delivery characteristics. This evidence concerns the gene AFP and preeclampsia.